Acute and long-term changes in T-lymphocyte subsets in response to clinical and subclinical measles. A community study from rural Senegal

Scandinavian Journal of Infectious Diseases

Volumn 30, Issue 1, 1998, Pages 17-21

  Lisse, Ida ^a   Samb, Badara ^b   Whittle, Hilton ^c   Jensen, Henrik ^d   Soumare, Masserigne ^e   Simondon, Francois ^b   Aaby, Peter ^b,d  

^a HVIDOVRE HOSPITAL   (Denmark)

^b INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (Senegal)

^c MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^d DEPARTMENT OF EPIDEMIOLOGY RESEARCH   (Denmark)

^e UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; MEASLES VACCINE;

ARTICLE; CHILD; CONTROLLED STUDY; CONVALESCENCE; EPIDEMIC; FATALITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; INCUBATION TIME; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEASLES; RASH; RURAL POPULATION; SENEGAL; SEX DIFFERENCE; T LYMPHOCYTE SUBPOPULATION;

ADOLESCENT; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MEASLES; MEASLES VACCINE; RURAL POPULATION; SENEGAL; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTE SUBSETS;

EID: 0031809216     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655498750002240     Document Type: Article

References (27)

1. Aaby P, Samb B, Simondon F, Coll Seck AM, Knudsen K, Whittle H. Non-spccilic beneficial effect of measles immunization: analysis of mortality studies from developing countries. BMJ 1995; 311: 481-5.
2. Clemens JD, Stanton BF. Chakraborty J, Chowdhury S, Rao MR. Ali M, et al. Measles vaccination and childhood mortality in rural Bangladesh. Am J Epidcmiol 1988; 128: 1330-9.
3. Aaby P, Samb B, Andersen M, Simondon F. No long-term excess mortality after measles infection: a community study from Senegal. Am J Epidemiol 1996; 143: 1035-41.
4. Aaby P, Lisse I, Molbak K, Knudsen K, Whittle H. No persistent T lymphocyte immunosuppression or increased mortality after measles infection: a community study from Guinea-Bissau. Pediatr Infect Dis J 1996; 15: 39-44.
5. Lisse IM, Whittle H, Aaby P, Normark M, Gyhrs A, Ryder LP. Labelling of T-cell subsets under field conditions in tropical countries. Adaptation of the immuno-alkaline phospatase staining method for blood-smears. J Immunol Meth 1990; 129: 49-53.
6. Garenne M. Variations in the age pattern of infant and child mortality with special reference to a case study in Ngayokheme (rural Senegal). PhD dissertation. University of Pennsylvania, 1982.
7. Garenne M, Maire B, Fontaine O, Dieng K, Briend A. Risques de décès associés à différents états nutritionels chez l'enfant d'âge préscolaire. Dakar: ORSTOM, 1987.
8. Chahnazarian A, Becker C, Delaunay V. Préziosi MP, Samb B, Simondon F, Simondon K. Population et santé à Niakhar, 1984 1991. Dakar: ORSTOM, 1992.
9. Garenne M, Aaby P. Pattern of exposure and measles mortality in Senegal. J Infect Dis 1990; 161: 1088-94.
10. Samb B, Aaby P, Whittle H, Coll Seck AM, Simondon F. Protective efficacy of high-titre measles vaecines administered from the age of five months in rural Senegal. Trans Roy Soc Trop Med Hyg 1993; 87: 697-701.
11. Aaby P, Samb B, Simondon F, Knudsen K, Coll Seek AM, Bennett J, et al. Sex-specific survival after high titre measles vaccines in rural Senegal. Bull WHO 1994; 72: 761-70.
12. Whittle HC, Mann G, Eccles M, O'Neill K, Jupp L, Hanlon P, et al. Effects of dose and strain of vaccine on success of measles vaccination of infants aged 4-5 months. Lancet 1988; i: 963-6.
13. Erber WN, Pinching AJ, Mason DY. Immunocytochemical detection of T and B cell populations in routine blood smears. Lancet 1984; i: 1042-6.
14. Coovadia HM, Wesley A, Brain P. Immunological events in acute measles influencing outcome. Arch Dis Child 1978; 53: 861-7.
15. Kiepiela P, Coovadia HM, Coward P. T helper cell defect related to severity of measles. Scand J Infect Dis 1987; 19: 185-92.
16. Arneborn P, Biberfeld G. T-lymphocyte subpopulations in relation to immunosuppression in measles and varicella. Infect Immunity 1983; 39: 29-37.
17. Wesley A, Coovadia HM, Henderson L. Immunological recovery after measles. Clin Exp Immunol 1978; 32: 540-4.
18. Dagan R, Phillip M, Sarov I, Epstein S, Kuperman O. Cellular immunity and T-lymphocyte subsets in young children with acute measles. J Med Virol 1987; 22: 175-82.
19. Joffe MI, Sukha NR, Rabson AR. Lymphocyte subsets in measles. Depressed helper/inducer subpopulation reversed by in vitro treatment with levamisole and ascorbic acid. J Clin Invest 1983; 72: 971-80.
20. Ohga S, Miyazaki C, Okada K, Akazawa K, Ueda K. The inflammatory cytokines in measles: correlation between serum interferon-gamma levels and lymphocyte subpopulations. Eur J Pediatr 1992; 151: 492-6.
21. Alpert G, Leibovitz L, Danon YL. Analysis of T-lymphocyte subsets in measles. J Int Dis 1984; 149: 1018.
22. Griffin DE, Ward BJ, Differential CD4 T cell activation in measles. J Infect Dis 1993; 168: 275-81.
23. Lisse IM, Böttiger B, Christensen LB, Knudsen K, Aaby P, Gottschau A, et al. Evaluation of T-cell subsets by an immunocytochemical method compared to flow cytometry in four countries. Scand J Immunol 1997; 45: 637-44.
24. Lisse I, Aaby P, Whittle H, Jensen H, Engelman M. T-lymphocyte subsets in West African children: impact of age, season and sex. J Pediatr 1997; 130: 77-85.
25. Aaby P, Bukh J, Kronborg D, Lisse IM, da Suva MC. Delayed excess mortality after exposure to measles during the first six months of life. Am J Epidemiol 1990; 132: 211-9.
26. Halsey N. Increased mortality following high titer measles vaccines: too much of a good thing. Pediatr Infect Dis J 1993; 12: 462-5.
27. Karp CL. Wysocka, Wahl LM, Aheam JM, Cuomo PJ, Sherry B, et al. Mechanism of suppression of cell-mediated immunity by measles infection. Science 1996; 273: 228-31.